Cytosolic arylamine N-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genes

Biochemical Pharmacology

Volumn 54, Issue 1, 1997, Pages 73-80

  Trepanier, Lauren A ^a,c   Ray, Kunal ^a   Winand, Nena J ^a   Spielberg, Stephen P ^b   Cribb, Alastair E ^b  

^a Department of Obstetrics Gynecology   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Animal Health Diagnostic Center   (United States)

Author keywords

Arylamine acetyltransferase; Deficiency; Dog; Gene; PABA; Sulfonamide

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DOG; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE DELETION; GENETIC ANALYSIS; LIVER; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

4-AMINOBENZOIC ACID; ANIMALS; ANIMALS, WILD; ARYLAMINE N-ACETYLTRANSFERASE; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CATS; CYTOSOL; DNA; DOGS; EVOLUTION, MOLECULAR; HUMANS; LIVER; MICE; POLYMERASE CHAIN REACTION; RABBITS; SULFAMETHAZINE;

EID: 0030855768     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00140-8     Document Type: Article

References (49)

1. Weber WW, The Acetylator Genes and Drug Response. Oxford University Press, New York, 1987.
2. Grant DM, Molecular genetics of the N-acetyltransferases. Pharmacogenetics 3: 45-50, 1993.
3. Minchin RF, Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by the recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307: 1-3, 1995.
4. Ward A, Summers MJ and Sim E, Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 49: 1759-1767, 1995.
5. Williams RT, Comparative patterns of drug metabolism. Fedn Proc 26: 1029-1039, 1967.
6. Short CR, Flory W, Hsieh LC, Aranas T, Ou S-P and Weissenger J, Comparison of hepatic drug metabolizing enzyme activities in several agricultural species. Comp Biochem Physiol 91C: 419-424, 1988.
7. 69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium. J Biol Chem 267: 8429-8436, 1992.
8. Blum M, Grant DM, Demierre A and Meyer UA, N-Acetylation pharmacogenetics: A gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits. Proc Natl Acad Sci USA 86: 9554-9557, 1989.
9. Martell KJ, Levy GN and Weber WW, Cloned mouse N-acetyltransferases: Enzymatic properties of expressed Nat-1 and Nat-2 gene products. Mol Pharmacol 42: 265-272, 1992.
10. Blum M, Demierre A, Grant DM, Heim M and Meyer UA, Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 88: 5237-5241, 1991.
11. Kelly SL and Sim E, Arylamine N-acetyltransferase in Balb/c mice: Identification of a novel mouse isozyme by cloning and expression in vitro. Biochem J 302: 347-353, 1994.
12. Ohsako S and Deguchi T, Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 265: 4630-4634, 1990.
13. Blum M, Grant DM, McBride W, Heim M and Meyer UA, Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression. DNA Cell Biol 9: 193-203, 1990.
14. Ohsako S, Ohtomi M, Sakamoto Y, Uyemura K and Deguchi T, Arylamine N-acetyltransferase from chicken liver. J Biol Chem 263: 7534-7538, 1988.
15. Blum M, Grant DM, Demierre A and Meyer UA, Nucleotide sequence of a full-length cDNA for arylamine N-acetyltransferase from rabbit liver. Nucleic Acids Res 17: 3589, 1989.
16. Martell KJ, Vatsis KP and Weber WW, Molecular genetic basis of rapid and slow acetylation in mice. Mol Pharmocol 40: 218-227, 1991.
17. Abu-Zeid M, Nagata K, Miyata M, Ozawa S, Fukuhara M, Yamazoe Y and Kato R, An arylamine acetyltransferase (AT-1) from Syrian golden hamster liver: Cloning, complete nucleotide sequence, and expression in mammalian cells. Mol Carcinog 4: 81-88, 1991.
18. Doll MA and Hein DW, Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 5: 247-251, 1995.
19. Marshall EK, Acetylation of sulfonamides in the dog. J Biol Chem 211: 499-503, 1954.
20. Bridges JW and Williams RT, Species differences in the acetylation of sulphanilamide. Biochem J 87: 19P, 1963.
21. Poirier LA, Miller JA and Miller EC, The N- and ring-hydroxylation of 2-acetylaminofluorene and the failure to detect N-acetylation of 2-aminofluorene in the dog. Cancer Res 23: 790-800, 1963.
22. Peters JH, Gordon GR, Biggs JT and Levy L, The disposition of dapsone and monoacetyldapsone in the dog. Proc Soc Exp Biol Med 148: 251-255, 1975.
23. Glinkuson T, Benjamin T, Grantham PH, Weisburger EK and Roller PP, Enzymic N-acetylation of 2,4-toluenediamine by liver cytosols from various species. Xenobiotica 5: 475-483, 1975.
24. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
25. Cribb AE, Grant DM, Miller M and Spielberg SP, Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes. J Pharmacol Exp Ther 259: 1241-1246, 1991.
26. Miller SA, Dykes DD and Polesky HF, A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
27. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K (Eds.), Short Protocols in Molecular Biology, 2nd Edn. John Wiley, New York, 1992.
28. Dupret J-M and Grant DM, Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. J Biol Chem 267: 7381-7385, 1992.
29. 2F) from rat stomach fundus. Mol Pharmacol 42: 549-557, 1992.
30. 1A receptor gene. J Biol Chem 265: 5825-5832, 1990.
31. Grant DM, Blum M, Beer M and Meyer UA, Monomorphic and polymorphic human arylamine N-acetyltransferases: A comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39: 184-191, 1991.
32. Sasaki Y, Ohsako S and Deguchi T, Molecular and genetic analyses of arylamine N-acetyltransferase polymorphism of rabbit liver. J Biol Chem 266: 13243-13259, 1991.
33. Gollamudi R, Rackley RJ and Autian J, A new substrate for the measurement of N-acetyltransferase activity. Enzyme 30: 155-161, 1983.
34. Vree TB, Reekers-Ketting JJ, Hekster CA and Nouws JFM, Acetylation and deacetylation of sulphonamides in dogs. J Vet Pharmacol Ther 6: 153-156, 1983.
35. Yamada H, Lee M-S and Wang CY, N- and O-Deacetylation of N-acetoxy-N-arylacetamides by mammalian hepatic microsomes. Carcinogenesis 9: 1995-2002, 1988.
36. Ferguson RJ, Doll MA, Rustan TD, Baumstark BR and Hein DW, Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: Amplification, cloning, sequencing, and expression in E. coli. Pharmacogenetics 4: 82-90, 1994.
37. Shear NH, Spielberg SP, Grant DM, Tang BK and Kalow W, Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 105: 179-184, 1986.
38. Rieder MJ, Shear NH, Kanee A, Tang BK and Spielberg SP, Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 49: 13-17, 1991.
39. Cribb AE, Lee BL, Trepanier LA and Spielberg SP, Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: Clinical syndromes and pachogenesis. Adverse Drug React Toxicol Rev 15: 9-50, 1996.
40. Lower GM Jr and Bryan GT, Enzymatic N-acetyiation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. Biochem Pharmacol 22: 1581-1588, 1973.
41. Shirota FN, Nagasawa HT, Kwon CH and Demaster EG, N-Acetylcyanamide, the major urinary metabolite of cyanamide in rat, rabbit, dog, and man. Drug Metab Dispos 12: 337-344, 1984.
42. Sone T, Zukowski K, Land SJ, King CM, Martin BM, Pohl LR and Wang CY, Characteristics of a purified dog hepatic microsomal N,O-acyltransferase. Carcinogenesis 15: 595-599, 1994.
43. Caldwell J, Comparative aspects of drug conjugation in laboratory animals, exotic species, and man. In: Comparative Veterinary Pharmacology, Toxicology, and Therapy (Eds. van Miert ASJPAM, Bogaert MG and Debackere M), pp. 285-294. MTP Press, Norwell, MA, 1985.
44. Nouws JFM, Vree TB, Breukink HJ, van Miert ASJPAM and Grondel J, Pharmacokinetics, hydroxylation, and acetylation of sulphadimidine in mammals, birds, fish, reptiles, and molluscs. In: Comparative Veterinary Pharmacology, Toxicology, and Therapy (Eds. van Miert ASJPAM, Bogaert MG and Debackere M), pp. 301-318. MTP Press, Norwell, MA, 1985.
45. Vree TB, Nouws JFM and Hekster YA, Comparative pharmacokinetic studies of sulphonamides. In: Comparative Veterinary Pharmacology, Toxicology, and Therapy (Eds. van Miert ASJPAM, Bogaert MG and Debackere M), pp. 173-185. MTP Press, Norwell, MA, 1985.
46. Weber WW and Hein DW, N-Acetylation pharmacogenetics. Pharmacol Rev 37: 25-79, 1985.
47. Nakura H, Itoh S, Kusano H, Ishizone H, Deguchi T and Kamataki T, Evidence for the lack of hepatic N-acetyltransferase in suncus (Suncus murinus). Biochem Pharmacol 50: 1165-1170, 1995.
48. MacDonald D, The Encyclopedia of Mammals. Facts on File Publications, New York, 1984.
49. Hickman D, Risch A, Buckle V, Spurr NK, Jeremiah SJ, McCarthy A and Sim E, Chromosomal localization of human genes for arylamine N-acetyltransferase. Biochem J 297: 441-445, 1994.